Final Prospectus · 424B4
CapsoVision, Inc.
CVNASDAQEQUITYCurrent
Final Prospectus
Company context
We are a global commercial-stage medical technology company focused on creating diagnostic and screening products to identify abnormalities of the GI tract. We develop advanced imaging and AI technologies in creating such products while maximizing the flexibility, convenience, profitability, and safety of patient care. We are a Delaware company, incorporated in 2005. Our corporate headquarters is located in Saratoga, California.
Current securities
As-filed source
As filedOpen full document ↗